Acurx Pharmaceuticals raises $1.1M in registered direct offering and private warrants

Acurx Pharmaceuticals, Inc.

Aggregate gross proceeds of ~$1.1M from 2.15M common shares and 595K pre-funded warrants at $0.40/share.
Private placement includes Series F warrants for up to 8.235M shares at $0.40, exercisable upon stockholder approval.
H.C. Wainwright exclusive placement agent; 7% cash fee plus warrants for 164,700 shares at $0.50.
Net proceeds to be used for working capital and general corporate purposes.
Offering expected to close on or about March 10, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.